Drug
Relugolix Combination Therapy
Relugolix Combination Therapy: highest development phase Phase 3, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Relugolix Combination Therapy NCT04756037 | Phase 3 | Contraception |
Latest
No recent events.
Follow Relugolix Combination Therapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.